NCT00737490View on ClinicalTrials.gov

Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT)

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

July 31, 2011

Conditions
CardiomyopathyHeart Failure
Interventions
OTHER

"Sequential Arm (Promote , model # 2207-36 or Atlas HF , model # V-343)"

"Echocardiographically guided optimized device programming: specifically sequential BiV pacing. Sequential Arm~Using one of the FDA approved St. Jude devices, depending on MD preference."

OTHER

"Simultaneous Arm (Promote , model # 2207-36 or Atlas HF , model # V-343)"

"simultaneous BiV pacing.~Using one of the FDA approved St. Jude devices, depending on MD preference."

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Abbott Medical Devices
All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

lead

Duke University

OTHER

NCT00737490 - Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT) | Biotech Hunter | Biotech Hunter